✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals
Market Cap
₹185 Cr.
P/E
17.49
About
Asarfi Hospital Limited is a multi-speciality hospital in Dhanbad, Jharkhand, providing valued healthcare services for over fifteen years. Accredited by NABL, the hospital offers prevention, treatment… Read more
Asarfi Hospital Limited is a multi-speciality hospital in Dhanbad, Jharkhand, providing valued… Read more
Low
53
52W Range
High
112
  • Asarfi Hospital Ltd.
  • Maitreya Medicare
  • Nephro Care India

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

7 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Distribution Channel

Therapeutic Area Wise Break-Up - API'S

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Operational Beds (.)
    • Occupancy Rate (%)
    • Number of Outpatient Visits - Quarterly (.)
    Peer Comparison
    FAQs on Asarfi Hospital Ltd. Business

    Asarfi Hospital Limited is an NABL accredited integrated healthcare service provider in Dhanbad, Jharkhand, offering multi-speciality care, prevention, treatment, and rehabilitation services for over 15 years. It is empanelled with Government Agencies, Corporates, Insurance, and TPA providers.

    Asarfi Hospital Ltd. major competitors are Maitreya Medicare, Nephro Care India, Lotus Eye Hospital, Vaidya Sane Ayur Lab, Aashka Hospitals, Unihealth Hospitals, Fortis MalarHospital.
    Market Cap of Asarfi Hospital Ltd. is ₹185 Crs.
    While the median market cap of its peers are ₹187 Crs.

    Asarfi Hospital Ltd. seems to be less financially stable compared to its competitors.
    Altman Z score of Asarfi Hospital Ltd. is 2.49 and is ranked 8 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation May Sep Dec
    Conference Call Sep
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material